Table 4.
Independent Factors for the Choice of Curative Treatment.
| Variables | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| P value | OR | 95% CI | p value | |
| Sex | 0.622 | |||
| Male | ||||
| Female | ||||
| Age (years), | 0.041 | 0.939 | 0.906-0.974 | 0.001 |
| PLT (×104/µL) | 0.267 | |||
| <15 | ||||
| ≥15 | ||||
| ALT (IU/L) | 0.356 | |||
| >60 | ||||
| ≤60 | ||||
| AFP (ng/mL) | 0.003 | |||
| >35 | 1 | Referent | ||
| ≤35 | 1.584 | 0.840-2.985 | 0.155 | |
| Child-Pugh class | <0.001 | |||
| B/C | 1 | Referent | ||
| A | 1.899 | 0.917-3.933 | 0.084 | |
| Tumor stage | <0.001 | |||
| III/IV | 1 | Referent | ||
| I/II | 6.918 | 3.550-13.484 | <0.001 | |
| Etiology | 0.517 | |||
| HBV | ||||
| HCV | ||||
| Optimal follow-up | <0.001 | |||
| Without | 1 | Referent | ||
| With | 3.213 | 1.615-6.391 | 0.001 | |
Abbreviations: RFA: radiofrequency ablation, OR: odds ratio, CI: confidence interval, PLT: platelet count, ALT: alanine aminotransferase, AFP: α-fetoprotein, HBV: hepatitis B virus, HCV: hepatitis C virus